LifeVantage Corporation

SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how five modern environmental toxins—pollution, microplastics, ultra-processed foods, hormone disruptors, and pesticides—affect cells and the role Protandim® Nrf2 can play in helping protect against their impact. † These findings further reinforce LifeVantage's position as a pioneer in nutrigenomics and the science behind its products that ignite the human body's natural defense systems.

Lifevantage Corporation (NASDAQ: LFVN - Get Free Report) crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $5.91 and traded as high as $5.99. Lifevantage shares last traded at $5.93, with a volume of 16,447 shares changing hands. Wall Street Analyst Weigh In

SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2026, after the stock market closes on Monday, November 9, 2026. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day.

CWH, LFVN and CGAU have been added to the Zacks Rank #5 (Strong Sell) List on October 19, 2026.